CA125 longitudinal decline kinetic is complementary to BRCA testing in first-line high grade serous ovarian carcinoma (HGSOC) patients (pts)

O. Becker, M. Chevrier, L. Gladieff,F. Joly Lobbedez, I. L. Ray-Coquard, A. Floquet, C. Pomel,H. Costaz,P. Pautier,T. De la Motte Rouge, R. Sabatier,J-M. Classe, E. Leblanc, F. Marchal,P-E. Colombo,E. Barranger,O. Colomban, L. Bosquet,B. You, M. J. Rodrigues

Annals of Oncology(2022)

引用 0|浏览1
暂无评分
关键词
serous ovarian carcinoma,longitudinal decline kinetic,brca testing,first-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要